Navigation Links
Managing Risk Through Quality: Ansell Healthcare's Innovative Gammex(R) Glove Range on Display at Arab Health 2009
Date:1/7/2009

BRUSSELS, January 7 /PRNewswire/ --

- Most Comprehensive Medical Glove Offering in the Middle-East

Ansell Healthcare, a global leader in barrier protective solutions having a 114-year history of R&D, will be showcasing the most recent offerings at the Arab Health fair in Dubai, from 26 to 29 January 2009 (Hall 6 Booth E10). Ansell invites healthcare workers to discover its comprehensive Gammex(R) range including the latest innovations in medical gloves and breakthroughs in safety. Ansell Healthcare will also participate in the Health Investment Seminar organised in partnership with the Ministry of Health of the Government of The Republic of Iraq in Dubai on the 24th and 25th of January 2009.

    Download complete press kit at
http://www.ansell.be/medical/index.cfm?page=arab_health_press&lang=EN

At the Ansell booth (Hall 6 Booth E10), visitors will discover the Gammex(R) PF (powder free) glove range in both latex and synthetic materials. The flagship of Ansell's surgical glove offering has been embraced by healthcare workers the world over for its combination of superior protection, comfort and great sensitivity. Gammex(R) PF is considered to be one of the safest surgical gloves on the market, with 'undetectable' allergen levels, according to FITkit(R) tests.

"We are already seeing a marked switch from powdered to powder-free gloves in Middle East healthcare practices," explains Werner Heintz, Ansell's Senior Vice President and Regional Director EMEA. "Before choosing synthetic materials, the first step in allergy prevention remains the reduction of allergens borne by powder, and in the latex formulation itself. According to us, quality powder-free latex gloves are an irreversible trend for the region."

Because Natural Rubber Latex (NRL) remains the recommended choice for barrier protection, Ansell Healthcare has been an early champion of powder-free latex gloves. On the prevention side, the company has optimised its NRL gloves to reduce water-soluble chemical residues, proteins and allergens. Another step towards prevention, the HydraSoft(R) hydrating technology, was integrated into the inner coating of Gammex(R) PF surgical gloves, helping to protect the skin's natural barrier when this is attacked by scrubbing and antiseptics.

An extensive range of white papers issued for AnsellCares by medical specialists can be consulted free-of-charge on the following website:

   http://www.ansell.be/medical/index.cfm?page=spec-prog_latex&lang=EN
    Note to editors:
    About Ansell
   http://www.ansell.eu.

Visit the press room for more information and pictures: http://www.ansell.be/medical/index.cfm?page=arab_health_press&lang=EN

    For more information about Ansell, please contact:
    Wouter Piepers,
    Director Communications, Ansell Healthcare
    tel: +32-2-528-75-68
    cellular: +32-478-33-56-32
    email: wpiepers@eu.ansell.com

    Olivier Trop
    Duval Guillaume I PR
    cellular: +32-486-510-419
    email: olivier.trop@duvalguillaume.com



'/>"/>
SOURCE Ansell Healthcare Europe nv
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Exclusive Conference on Managing Your Online Brand: Shaping the Noise from the Blogosphere
2. Dan Renick, RPh, Joins The Hobart Group as Managing Partner
3. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
4. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
5. Cynthia Haines, M.D., Named Managing Editor of Physicians Briefing News Wire
6. Codexis Appoints Singapore Laboratories Managing Director
7. Third Security, LLC Hires Two New Managing Directors
8. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
9. Governor Rendell Says Life Science Industry Will Fuel New Breakthroughs, Generate Jobs for Decades to Come
10. Bell Ventures Launches Breakthrough Radical Defense Skin Care Ingredient
11. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , ... March 22, 2017 , ... ... human tissue regeneration from small lab samples to full-size tissues, bones, even whole ... establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):